Ekso Bionics (EKSO) Short Interest Ratio & Short Volume

Short interest is the volume of Ekso Bionics shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 33,900 shares of EKSO short. 0.29% of Ekso Bionics' shares are currently sold short. Learn More on Ekso Bionics' current short interest.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Ekso Bionics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.29% of Ekso Bionics' floating shares are currently sold short.

Ekso Bionics saw a drop in short interest during the month of October. As of October 31st, there was short interest totaling 33,900 shares, a drop of 2.3% from the previous total of 34,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Ekso Bionics currently has issued a total of 14,235,000 shares. Some of Ekso Bionics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Ekso Bionics currently has a public float of 11,560,000 shares.

0.29% of Ekso Bionics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Ekso Bionics: Entera Bio Ltd. (0.25%), Viracta Therapeutics, Inc. (2.56%), Oncternal Therapeutics, Inc. (0.70%), NuCana plc (0.39%), Pieris Pharmaceuticals, Inc. (0.19%), Purple Biotech Ltd. (3.18%), Modular Medical, Inc. (0.60%), Khosla Ventures Acquisition Co. (0.91%), Data Knights Acquisition Corp. (0.29%), Elevation Oncology, Inc. (2.84%),

As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($9.07 billion), T-Mobile US, Inc. ($3.71 billion), Charter Communications, Inc. ($3.51 billion), Occidental Petroleum Co. ($2.81 billion), Lululemon Athletica Inc. ($2.35 billion), Tractor Supply ($2.26 billion), Coinbase Global, Inc. ($1.88 billion), Rivian Automotive, Inc. ($1.71 billion), Celsius Holdings, Inc. ($1.67 billion), and Newmont Co. ($1.66 billion). View all of the most shorted stocks.

Short selling EKSO is an investing strategy that aims to generate trading profit from Ekso Bionics as its price is falling. EKSO shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Ekso Bionics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EKSO, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EKSO, twice per month. The most recent reporting period available is October, 31 2023.